<code id='86E838DBEC'></code><style id='86E838DBEC'></style>
    • <acronym id='86E838DBEC'></acronym>
      <center id='86E838DBEC'><center id='86E838DBEC'><tfoot id='86E838DBEC'></tfoot></center><abbr id='86E838DBEC'><dir id='86E838DBEC'><tfoot id='86E838DBEC'></tfoot><noframes id='86E838DBEC'>

    • <optgroup id='86E838DBEC'><strike id='86E838DBEC'><sup id='86E838DBEC'></sup></strike><code id='86E838DBEC'></code></optgroup>
        1. <b id='86E838DBEC'><label id='86E838DBEC'><select id='86E838DBEC'><dt id='86E838DBEC'><span id='86E838DBEC'></span></dt></select></label></b><u id='86E838DBEC'></u>
          <i id='86E838DBEC'><strike id='86E838DBEC'><tt id='86E838DBEC'><pre id='86E838DBEC'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:67
          Stock ticker
          Adobe

          You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

          ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

          advertisement

          What if sometimes cancer doctors could give less medicine?

          Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          Methadone doses haven’t kept up in the age of fentanyl
          Methadone doses haven’t kept up in the age of fentanyl

          Ahealthcareworkermeasuresadoseofmethadone.PHILLMAGAKOE/AFPviaGettyImagesPatientsbeginningtreatmentfo

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Naloxone nonprofit donates 200,000 doses after FDA approval

          RiViveisthesecondnaloxoneproducttoreceiveclearancetobesoldoverthecounter.HarmReductionTherapeuticsAn